U.S. Markets open in 6 hrs 7 mins

The Zacks Analyst Blog Highlights: Apache, Continental Resources, KMG Chemicals, ZAGG and AbbVie

Zacks Equity Research
URBN vs. TPR: Which Stock Is the Better Value Option?

For Immediate Release

Chicago, IL – July 10, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Apache Corp. APA, Continental Resources, Inc. CLR, KMG Chemicals, Inc. KMG, ZAGG Inc ZAGG and AbbVie Inc. ABBV.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Monday’s Analyst Blog:

Celebrate Trump’s 2nd Year in Office with These 5 Winners

It’s time to celebrate President Trump’s second year in office. After all, in two out of every three times, the second years of presidential terms have favored stock investors.

Wall Street, by the way, has shown enough confidence even as concerns about trade war loom large. As a matter of fact, solid job additions last month and an economy poised for growth that could come teasingly close to a milestone achieved in 2005 have instilled confidence among investors.

Given the bullishness, investing in stocks with solid growth potential doesn’t seem to be a bad proposition.

Wall Street Usually Rises in 2nd Year of Presidential Terms

There is always a 67% chance that the U.S. stock market will scale north during the second years of presidential terms. The Dow Jones Industrial Average, since its inception in 1896, has risen in two out of three times on average during the said period. And when the stock market rises less than 2% in the first half, you can be assured that it’s a done deal. Needless to say, the broader S&P 500 index rose less than 2% in the first half of this year.

Even when the markets are fraught with concerns about geopolitical tensions or pending U.S. mid-term elections, you can pin your hopes on the success of the second year of a presidential term. And why not? The stock market is always forward looking and has already discounted such issues. Further, these odds won’t get hampered even if it is an aging bull market. This is why, there is a saying that bull markets don’t die of old age.

% of time DJIA rises during the 2nd years of presidential terms (Data: Since 1896)

Underlying Fundamentals Point the Way Higher

Stocks, by the way, have remained resilient to potential threats such U.S.-China trade skirmish after the White House imposed tariffs on $34 billion worth of Chinese goods, compelling Beijing to retaliate (read more: Think Small As U.S.-China Trade War Breaks Out! 5 Top Picks).

Bulls also have solid faith in the underlying strengths of the U.S. economy and perhaps that points the way higher. The United States has been able to create 213,000 jobs in June; a healthy sign that show corporates are finding ways to fill open jobs despite lack of skilled workers. Such hiring figures easily topped analysts’ estimates of 200,000 job additions.

Job gains were pretty broad based, with white-collar jobs leading the way with 50,000 job additions. From manufacturers, health-care providers to construction companies, all hired workers, a clear sign of a burgeoning economy.

The unemployment rate rose to 4% last month, but for a good reason. The jobless rate went up mostly because of around 600,000 people entering the labor force. This showed that more Americans are searching for jobs as they are easier to find.

Companies, in the meanwhile, are raising pay and benefits. Hourly wages rose 5 cents to $26.98. The yearly rate of pay hikes remained unchanged at 2.7%.

Ramped up business investments, in a way, is expected to help the economy gain traction. The U.S. economy is projected to expand in the second quarter at an annual pace of nearly 4% after a 2.2% gain in the first three months of this year, economists say. This would put the economy in a solid position this year to meet or even beat 3% growth in gross domestic product (GDP), one of the primary aims of the government (read more: US GDP to Hit Elusive 3% Annual Growth in 13 Years: 5 Picks).

Pundits Remain Sanguine About the U.S. Equity Outlook

A number of market pundits remain upbeat about the outlook for U.S. equities. They have looked beyond potential headwinds that have been hurting the markets so far this year. In fact, analysts at JPMorgan Chase & Co. have said that upbeat economic data coupled with pro-business policies will help companies register double-digit growth and accelerate buybacks in the near term.

Dubravko Lakos-Bujas, the firm’s head of equity strategy, raised his year-end target for the S&P to 3,000 (8.7% upside potential from the current level).

Tobias Levkovich, Citigroup’s chief U.S. strategist, is also upbeat, upgrading his rating to overweight from neutral and setting a price a price target of 2,865 for the S&P (3.8% upside potential from the current level).

Andrew Adams, a strategist at Raymond James, in the meantime said that even though this year has seen a more torrid run than last year, he is yet to see red flags that indicate that the bull run is near its end. In fact, he has urged investors to look at the long-term trend and remain bullish.

5 Stocks With Solid Upside Potential in the Second half

Wall Street is gaining traction despite headlines flashing warnings about trade war. At the same time, statistical evidence shows that Trump’s second year in office will be fruitful for the stock market. Thus, investing in stocks that can make the most of these bullish trends seems judicious.

We have, hence, selected five stocks that flaunt a Zacks Rank #1 (Strong Buy) or 2 (Buy) and a Growth Score of A or B, as it offers the best investment opportunities in the growth investing space.

Apache Corp. is an independent energy company. The stock currently has a Zacks Rank #2 and a Growth Score of A. In the last 60 days, seven earnings estimates moved north, while one moved south for the current year. The Zacks Consensus Estimate for earnings rose 29.6% in the same period. The company’s expected earnings growth rate for the current year is 629.2% compared with the Oil and Gas - Exploration and Production - United States industry’s projected rally of 20.1%.

Continental Resources, Inc. explores for, develops, and produces crude oil and natural gas properties in the north, south, and east regions of the United States. The stock currently has a Zacks Rank #1 and a Growth Score of B. In the last 60 days, 11 earnings estimates moved north, while none moved south for the current year. The Zacks Consensus Estimate for earnings increased 20.4% in the same period. The company’s expected earnings growth rate for the current year is 535.3% compared with the Oil and Gas - Exploration and Production - United States industry’s expected gain of 20.1%.

KMG Chemicals, Inc. manufactures, formulates, and distributes specialty chemicals and performance materials worldwide. The stock currently has a Zacks Rank #1 and a Growth Score of B. In the last 60 days, three earnings estimates moved up, while none moved down for the current year. The Zacks Consensus Estimate for earnings increased nearly 13% in the same period. The company’s expected earnings growth rate for the current year is 76.2% compared with the Chemical - Specialty industry’s estimated rally of 18.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.

ZAGG Inc designs, manufactures, and distributes mobile tech accessories for smartphones and tablets in the United States and internationally. The stock currently has a Zacks Rank #1 and a Growth Score of B. In the last 60 days, one earnings estimate moved north, while none moved south for the current year. The Zacks Consensus Estimate for earnings advanced 1.4% in the same period. The company’s expected earnings growth rate for the current year is 44.3% compared with the Electronics - Miscellaneous Components industry’s projected rally of 21.1%.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The stock currently has a Zacks Rank #2 and a Growth Score of B. In the last 60 days, two earnings estimates moved north, while none moved south for the current year. The Zacks Consensus Estimate for earnings rose 0.3% in the same period. The company’s expected earnings growth rate for the current year is 39.3% compared with the Large Cap Pharmaceuticals industry’s estimated growth of 7.4%.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.  

See the pot trades we're targeting>>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
KMG Chemicals, Inc. (KMG) : Free Stock Analysis Report
 
ZAGG Inc (ZAGG) : Free Stock Analysis Report
 
Apache Corporation (APA) : Free Stock Analysis Report
 
Continental Resources, Inc. (CLR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.